Aurobindo Pharma`s Generic Mycophenolic Sodium Receives Approval in the U.S.
27 Feb 2024 //
FDA
CellCept,MYFORTIC-Risk of Teratogenicity in Mycophenolate-Containing Products
12 Jan 2015 //
HEALTH CANADA
27 Feb 2024 //
FDA
12 Jan 2015 //
HEALTH CANADA